Angewandte
Chemie
Table 2: Rh-catalyzed asymmetric hydrogenation of b,g-unsaturated carboxylic acids 1.[a]
Entry
1
R
Product
Yield [%][b]
ee [%][c]
Config.[d]
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
a
b
c
d
e
f
g
h
i
j
k
l
m
n
o
phenyl
2a
2b
2c
2d
2e
2 f
2g
2h
2i
2j
2k
2l
2m
2n
2o
93
91
93
94
95
92
93
90
93
91
94
93
97
92
85
97
98
96
97
97
94
>99
95
>99
98
98
S (+)
(À)
2-Me-C6H4
3-Me-C6H4
4-Me-C6H4
3-OMe-C6H4
4-OMe-C6H4
3-F-C6H4
(+)
(+)
(+)
S (+)
(+)
(+)
(+)
(+)
(+)
R (À)
S (+)
R (+)
R (+)
4-F-C6H4
4-Cl-C6H4
4-Br-C6H4
4-CF3-C6H4
1-naphthyl
2-naphthyl
benzyl
98
97
74
70
n-butyl
[a] Reactions were carried out with 0.1 mol% of Rh-DuanPhos complex and 5 mol% Et3N for 12 h under an initial hydrogen pressure of 3 atm in
MeOH/H2O (1:1). In all cases 1H NMR spectroscopy indicated complete conversion. [b] Yield of isolated product. [c] The enantiomeric excesses were
determined by chiral HPLC or chiral GC (see the Supporting Information). [d] The absolute configurations of 2a, 2 f, 2l, 2m, 2n, and 2o were assigned
by comparison of the observed optical rotation with reported data.
by chiral GC (Gamma Dex 225 and Beta Dex 325) or HPLC (Chiral
OD and OJ-H).
DuanPhos. High turnover numbers for selected substrates
were also achieved under mild conditions. This strategy
establishes one of the most practical methods for the synthesis
of enantiomerically pure 3-arylbutanoic acids and their
derivatives, which are important pharmaceutical intermedi-
ates and chiral building blocks in organic synthesis. Further
investigation of the substrate scope with this catalytic system
will be reported in due course.
Received: November 27, 2006
Published online: March 6, 2007
Keywords: asymmetric catalysis · carboxylic acids ·
.
enantioselectivity · hydrogenation · rhodium
[1] a) C. Fuganti, S. Serra, A. Dulio, J. Chem. Soc. Perkin Trans. 1
1999, 279 – 282; b) C. Fuganti, S. Serra, J. Chem. Soc. Perkin
Trans. 1 2000, 3758 – 3764; c) A. I. Meyers, D. Stoianova, J. Org.
Chem. 1997, 62, 5219 – 5221.
[2] a) E. Nicolas, K. C. Russell, J. Knollenberg, V. J. Hruby, J. Org.
Chem. 1993, 58, 7565 – 7571; b) A. J. Birch, J. E. T. Corrie, P. L.
Macdonald, G. Subba Rao, J. Chem. Soc. Perkin Trans. 1 1972,
1186 – 1190; c) K. Mori, Tetrahedron: Asymmetry 2005, 16, 685 –
692; d) T. Lee, J. B. Jones, J. Am. Chem. Soc. 1997, 119, 10260 –
10268.
[3] a) B. E. Rossiter, N. M. Swingle, Chem. Rev. 1992, 92, 771 – 806;
b) Z. J. Song, M. Zhao, R. Desmond, P. Devine, D. M. Tschaen,
R. Tillyer, L. Frey, R. Heid, F. Xu, B. Li, J. Foster, R. Reamer, R.
Volante, E. J. J. Grabowski, U. H. Dolling, P. J. Reider, S. O.
Okada, Y. Kato, E. Mano, J. Org. Chem. 1999, 64, 9658 – 9667;
c) Z. J. Song, M. Zhao, L. Frey, J. Li, L. Tan, C. Y. Chen, D. M.
Tschaen, R. Tillyer, E. J. J. Grabowski, R. Volante, P. J. Reider,
Y. Kato, S. Okada, T. Nemoto, H. Sato, A. Akao, T. Mase, Org.
Lett. 2001, 3, 3357 – 3360; d) Y. Kato, K. Niiyama, T. Nemoto, H.
Jona, A. Akao, S. Okada, Z. J. Song, M. Zhao, Y. Tsuchiya, K.
Tomimoto, T. Mase, Tetrahedron 2002, 58, 3409 – 3415.
[4] a) M. P. Sibi, S. Manyem, Tetrahedron 2000, 56, 8033 – 8061;
b) K. Fagnou, M. Lautens, Chem. Rev. 2003, 103, 169 – 196; c) T.
Hayashi, K. Yamasaki, Chem. Rev. 2003, 103, 2829 – 2844; d) F.
Menges, A. Pfaltz, Adv. Synth. Catal. 2002, 344, 40 – 44.
[5] M. C. Hillier, J. N. Desrosiers, J. F. Marcoux, E. J. J. Grabowski,
Org. Lett. 2004, 6, 573 – 576.
Experimental Section
General procedure: Asuspension of ( Sp,Rc)-DuanPhos (140 mg,
0.366 mmol) in THF (6 mL) was added to a solution of [Rh-
(nbd)2]SbF6 (182.6 mg, 0.35 mmol) in THF (2 mL) at À208C. The
resulting red solution was allowed to warm to room temperature and
stirred for an additional 15 min. The solution was concentrated to
about 6 mL. Then Et2O (25 mL) was added under vigorous stirring,
during which an orange precipitate was formed. The precipitate was
filtered off and washed with Et2O (2 10 mL) to afford the orange
solid complex (198 mg, 67%).[15] The complex was stored in a
nitrogen-filled glovebox for further usage. The complex (16.3 mg,
0.02 mmol) was dissolved in degassed methanol (100 mL) in a
glovebox. A10-mL portion of the complex solution was divided
equally among 10 vials. Et3N (1.01 mg, 0.01 mmol) in 1 mL of
degassed water was added to each of the vials, followed by b,g-
unsaturated acid substrate (0.2 mmol, S/C = 1000). The resulting
solution was then transferred into an autoclave and charged with
3 atm of hydrogen. The hydrogenation was performed at room
temperature for 12 h. The hydrogen was released carefully, and the
solvent was removed by evaporation. The residue was dissolved in
diethyl ether (20 mL) and extracted with 3 equivalents of aq. NaOH
(2 30 mL). The alkaline solution was acidified with 6 equivalents of
aq. HCl, and then extracted with diethyl ether (3 20 mL). The ether
extracts were washed with brine, dried over anhydrous Na2SO4, and
concentrated by evaporation. The residue was subject to silica gel
column chromatography using hexanes/ether (8:1) as eluent for
further purification. Enantiomeric excesses were directly measured
[6] a) C.-C. Pai, C.-W. Lin, C.-C. Lin, C.-C. Chen, A. S. C. Chan, J.
Am. Chem. Soc. 2000, 122, 11513 – 11514; b) T. Ohta, H. Takaya,
Angew. Chem. Int. Ed. 2007, 46, 2623 –2626
ꢀ 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
2625